“IDH-mutant glioblastomas” were often considered secondary neoplasms (i.e., progressed from lower-grade IDH-mutant astrocytomas), while IDH-wildtype glioblastomas typically represented de novo neoplasms, mainly in older adults (9). This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).